0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Endocrinology Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-14B9455
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Endocrinology Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Endocrinology Drugs Market Research Report 2025

Code: QYRE-Auto-14B9455
Report
September 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Endocrinology Drugs Market Size

The global market for Endocrinology Drugs was valued at US$ 107400 million in the year 2024 and is projected to reach a revised size of US$ 152890 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Endocrinology Drugs Market

Endocrinology Drugs Market

Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Endocrinology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrinology Drugs.
The Endocrinology Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endocrinology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrinology Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Endocrinology Drugs Market Report

Report Metric Details
Report Name Endocrinology Drugs Market
Accounted market size in year US$ 107400 million
Forecasted market size in 2031 US$ 152890 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Diabetes Drugs
  • Testosterone Replacement Drugs
  • Human Growth Hormone Drugs
  • Thyroid Hormone Disorder Drugs
Segment by Application
  • Hospitals
  • Commercial Laboratories
  • Ambulatory Care Centres
  • Other Setting
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Endocrinology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Endocrinology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Endocrinology Drugs Market growing?

Ans: The Endocrinology Drugs Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Endocrinology Drugs Market size in 2031?

Ans: The Endocrinology Drugs Market size in 2031 will be US$ 152890 million.

Who are the main players in the Endocrinology Drugs Market report?

Ans: The main players in the Endocrinology Drugs Market are AbbVie, AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi

What are the Application segmentation covered in the Endocrinology Drugs Market report?

Ans: The Applications covered in the Endocrinology Drugs Market report are Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting

What are the Type segmentation covered in the Endocrinology Drugs Market report?

Ans: The Types covered in the Endocrinology Drugs Market report are Diabetes Drugs, Testosterone Replacement Drugs, Human Growth Hormone Drugs, Thyroid Hormone Disorder Drugs

1 Endocrinology Drugs Market Overview
1.1 Product Definition
1.2 Endocrinology Drugs by Type
1.2.1 Global Endocrinology Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Diabetes Drugs
1.2.3 Testosterone Replacement Drugs
1.2.4 Human Growth Hormone Drugs
1.2.5 Thyroid Hormone Disorder Drugs
1.3 Endocrinology Drugs by Application
1.3.1 Global Endocrinology Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Commercial Laboratories
1.3.4 Ambulatory Care Centres
1.3.5 Other Setting
1.4 Global Endocrinology Drugs Market Size Estimates and Forecasts
1.4.1 Global Endocrinology Drugs Revenue 2020-2031
1.4.2 Global Endocrinology Drugs Sales 2020-2031
1.4.3 Global Endocrinology Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Endocrinology Drugs Market Competition by Manufacturers
2.1 Global Endocrinology Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Endocrinology Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Endocrinology Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Endocrinology Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Endocrinology Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Endocrinology Drugs, Product Type & Application
2.7 Global Key Manufacturers of Endocrinology Drugs, Date of Enter into This Industry
2.8 Global Endocrinology Drugs Market Competitive Situation and Trends
2.8.1 Global Endocrinology Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Endocrinology Drugs Players Market Share by Revenue
2.8.3 Global Endocrinology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Endocrinology Drugs Market Scenario by Region
3.1 Global Endocrinology Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Endocrinology Drugs Sales by Region: 2020-2031
3.2.1 Global Endocrinology Drugs Sales by Region: 2020-2025
3.2.2 Global Endocrinology Drugs Sales by Region: 2026-2031
3.3 Global Endocrinology Drugs Revenue by Region: 2020-2031
3.3.1 Global Endocrinology Drugs Revenue by Region: 2020-2025
3.3.2 Global Endocrinology Drugs Revenue by Region: 2026-2031
3.4 North America Endocrinology Drugs Market Facts & Figures by Country
3.4.1 North America Endocrinology Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Endocrinology Drugs Sales by Country (2020-2031)
3.4.3 North America Endocrinology Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Endocrinology Drugs Market Facts & Figures by Country
3.5.1 Europe Endocrinology Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Endocrinology Drugs Sales by Country (2020-2031)
3.5.3 Europe Endocrinology Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endocrinology Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Endocrinology Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Endocrinology Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Endocrinology Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Endocrinology Drugs Market Facts & Figures by Country
3.7.1 Latin America Endocrinology Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Endocrinology Drugs Sales by Country (2020-2031)
3.7.3 Latin America Endocrinology Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Endocrinology Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Endocrinology Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Endocrinology Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Endocrinology Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Endocrinology Drugs Sales by Type (2020-2031)
4.1.1 Global Endocrinology Drugs Sales by Type (2020-2025)
4.1.2 Global Endocrinology Drugs Sales by Type (2026-2031)
4.1.3 Global Endocrinology Drugs Sales Market Share by Type (2020-2031)
4.2 Global Endocrinology Drugs Revenue by Type (2020-2031)
4.2.1 Global Endocrinology Drugs Revenue by Type (2020-2025)
4.2.2 Global Endocrinology Drugs Revenue by Type (2026-2031)
4.2.3 Global Endocrinology Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Endocrinology Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Endocrinology Drugs Sales by Application (2020-2031)
5.1.1 Global Endocrinology Drugs Sales by Application (2020-2025)
5.1.2 Global Endocrinology Drugs Sales by Application (2026-2031)
5.1.3 Global Endocrinology Drugs Sales Market Share by Application (2020-2031)
5.2 Global Endocrinology Drugs Revenue by Application (2020-2031)
5.2.1 Global Endocrinology Drugs Revenue by Application (2020-2025)
5.2.2 Global Endocrinology Drugs Revenue by Application (2026-2031)
5.2.3 Global Endocrinology Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Endocrinology Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Endocrinology Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Endocrinology Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Endocrinology Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Endocrinology Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Endocrinology Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Endocrinology Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Endocrinology Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Endocrinology Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Novo Nordisk
6.5.1 Novo Nordisk Company Information
6.5.2 Novo Nordisk Description and Business Overview
6.5.3 Novo Nordisk Endocrinology Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novo Nordisk Endocrinology Drugs Product Portfolio
6.5.5 Novo Nordisk Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Company Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Endocrinology Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi Endocrinology Drugs Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Endocrinology Drugs Industry Chain Analysis
7.2 Endocrinology Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endocrinology Drugs Production Mode & Process Analysis
7.4 Endocrinology Drugs Sales and Marketing
7.4.1 Endocrinology Drugs Sales Channels
7.4.2 Endocrinology Drugs Distributors
7.5 Endocrinology Drugs Customer Analysis
8 Endocrinology Drugs Market Dynamics
8.1 Endocrinology Drugs Industry Trends
8.2 Endocrinology Drugs Market Drivers
8.3 Endocrinology Drugs Market Challenges
8.4 Endocrinology Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Endocrinology Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Endocrinology Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Endocrinology Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Endocrinology Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Endocrinology Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Endocrinology Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Endocrinology Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Endocrinology Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Endocrinology Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Endocrinology Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Endocrinology Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Endocrinology Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Endocrinology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrinology Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Endocrinology Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Endocrinology Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Endocrinology Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Endocrinology Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Endocrinology Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Endocrinology Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Endocrinology Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Endocrinology Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Endocrinology Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Endocrinology Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Endocrinology Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Endocrinology Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Endocrinology Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Endocrinology Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Endocrinology Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Endocrinology Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Endocrinology Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Endocrinology Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Endocrinology Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Endocrinology Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Endocrinology Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Endocrinology Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Endocrinology Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Endocrinology Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Endocrinology Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Endocrinology Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Endocrinology Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Endocrinology Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Endocrinology Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Endocrinology Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Endocrinology Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Endocrinology Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Endocrinology Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Endocrinology Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Endocrinology Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Endocrinology Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Endocrinology Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Endocrinology Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Endocrinology Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Endocrinology Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Endocrinology Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Endocrinology Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Endocrinology Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Endocrinology Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Endocrinology Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Endocrinology Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Endocrinology Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Endocrinology Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Endocrinology Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Endocrinology Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Endocrinology Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Endocrinology Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Endocrinology Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Endocrinology Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Endocrinology Drugs Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca Endocrinology Drugs Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Eli Lilly Endocrinology Drugs Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Merck Endocrinology Drugs Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Novo Nordisk Company Information
 Table 91. Novo Nordisk Description and Business Overview
 Table 92. Novo Nordisk Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Novo Nordisk Endocrinology Drugs Product
 Table 94. Novo Nordisk Recent Developments/Updates
 Table 95. Sanofi Company Information
 Table 96. Sanofi Description and Business Overview
 Table 97. Sanofi Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Sanofi Endocrinology Drugs Product
 Table 99. Sanofi Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Endocrinology Drugs Distributors List
 Table 103. Endocrinology Drugs Customers List
 Table 104. Endocrinology Drugs Market Trends
 Table 105. Endocrinology Drugs Market Drivers
 Table 106. Endocrinology Drugs Market Challenges
 Table 107. Endocrinology Drugs Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Endocrinology Drugs
 Figure 2. Global Endocrinology Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Endocrinology Drugs Market Share by Type: 2024 & 2031
 Figure 4. Diabetes Drugs Product Picture
 Figure 5. Testosterone Replacement Drugs Product Picture
 Figure 6. Human Growth Hormone Drugs Product Picture
 Figure 7. Thyroid Hormone Disorder Drugs Product Picture
 Figure 8. Global Endocrinology Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Endocrinology Drugs Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Commercial Laboratories
 Figure 12. Ambulatory Care Centres
 Figure 13. Other Setting
 Figure 14. Global Endocrinology Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Endocrinology Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Endocrinology Drugs Sales (2020-2031) & (K Units)
 Figure 17. Global Endocrinology Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 18. Endocrinology Drugs Report Years Considered
 Figure 19. Endocrinology Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Endocrinology Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Endocrinology Drugs Players: Market Share by Revenue in Endocrinology Drugs in 2024
 Figure 22. Endocrinology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Endocrinology Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Endocrinology Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Endocrinology Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Endocrinology Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Endocrinology Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Endocrinology Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Endocrinology Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Endocrinology Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Endocrinology Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Endocrinology Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Endocrinology Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Endocrinology Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Endocrinology Drugs by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Endocrinology Drugs by Type (2020-2031)
 Figure 59. Global Endocrinology Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Endocrinology Drugs by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Endocrinology Drugs by Application (2020-2031)
 Figure 62. Global Endocrinology Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 63. Endocrinology Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Liraglutide Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11A9578
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Diabetes Care Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I8272
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Thyroid Gland Disorder Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16N11302
Mon Sep 08 00:00:00 UTC 2025

Add to Cart